Internal Medicine, Endocrinology, Diabetes, & Metabolism · Riverhead, NY
NPI
1144280827
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
189 Main Rd
Riverhead, NY, 11901
Phone (631) 288-7120
Groups this clinician bills Medicare through
Medicare paid, 2024
$235K
5,060 services
Medicare patients, 2024
949
Average age 75
Drug cost, 2024
$3.6M
6,122 prescriptions
Company payments, 2025
$414
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alan Goldenberg was code 99214 (office e&m - established), 1,589 times for 790 patients. In total Alan Goldenberg billed 5,060 services in 18 codes, and Medicare paid $235K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-02-25.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,589 | 790 | $105.12 | $167K |
| 82962 Clinical Chemistry | Office | 719 | 336 | $3.17 | $2,282 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 685 | 567 | $14.63 | $10K |
| 36415 Venipuncture Blood Collection | Office | 282 | 186 | $8.65 | $2,439 |
| 99204 Office E&M - New | Office | 153 | 153 | $141.00 | $22K |
| 95251 Test - Miscellaneous | Office | 103 | 51 | $29.37 | $3,025 |
| 99213 Office E&M - Established | Office | 71 | 68 | $71.58 | $5,082 |
| 99203 Office E&M - New | Office | 44 | 44 | $93.49 | $4,114 |
By year: 2022 $211K for 2,896 services; 2023 $207K for 3,012 services; 2024 $235K for 5,060 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82962 Clinical Chemistry | 719 | 336 | $3.17 | $2,282 |
| 36415 Venipuncture Blood Collection | 282 | 186 | $8.65 | $2,439 |
Medicare prescription drug claims, 2024
In 2024, the drug Alan Goldenberg prescribed most often to Medicare patients was Levothyroxine Sodium, with 654 prescriptions and refills. In total Alan Goldenberg wrote 6,122 Medicare prescriptions that cost $3.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 654 | 1,786 | 216 | $11K |
| Pioglitazone Hcl Generic | 558 | 1,503 | 176 | $9,386 |
| Synthroid Levothyroxine Sodium | 401 | 1,140 | 124 | $34K |
| Jardiance Empagliflozin | 382 | 948 | 117 | $543K |
| Metformin Hcl Generic | 331 | 896 | 107 | $2,879 |
| Mounjaro Tirzepatide | 319 | 543 | 77 | $570K |
| Trulicity Dulaglutide | 270 | 509 | 75 | $489K |
| Januvia Sitagliptin Phosphate | 203 | 462 | 64 | $246K |
| Farxiga Dapagliflozin Propanediol | 199 | 469 | 71 | $252K |
| Glimepiride Generic | 194 | 559 | 66 | $2,698 |
| Methimazole Generic | 177 | 480 | 65 | $2,236 |
| Metformin Hcl Er Metformin Hcl | 166 | 473 | 66 | $2,778 |
| Atorvastatin Calcium Generic | 155 | 455 | 59 | $1,998 |
| Ozempic Semaglutide | 147 | 322 | 44 | $301K |
| Rosuvastatin Calcium Generic | 127 | 354 | 51 | $2,202 |
Brand drugs: 2,917 claims; generic drugs: 2,999 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alan Goldenberg $414 ($414 in general payments such as food, travel and fees) from 12 companies. The largest payer was Amgen Inc. with $69.12.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 3 | $69.12 |
| Abbott Laboratories ABT | 3 | $60.83 |
| Xeris Pharmaceuticals, Inc. | 2 | $48.75 |
| Madrigal Pharmaceuticals MDGL | 1 | $37.27 |
| Corcept Therapeutics CORT | 2 | $35.49 |
| Alexion Pharmaceuticals, Inc. AZN | 1 | $28.98 |
| Novo Nordisk Inc NVO | 1 | $26.18 |
| Tandem Diabetes Care, Inc. TNDM | 1 | $24.46 |
| Recordati_rare_diseases_inc. | 1 | $24.27 |
| Lilly USA, LLC LLY | 1 | $22.22 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.